ForDoz Pharma Corporation
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ForDoz Pharma Corporation
New company licenses obicetrapib from Amgen after previous companies’ setbacks in CETP class and works with FDA on a Phase III protocol. BMS buys protein-engineering specialist Forbius.
- Contract Research, Toxicology Testing-CRO
- Contract Manufacturing Organization
- Specialty Pharmaceuticals